Medibyt Wins FDA Clearance for CPETWise Analysis Platform
Herzliya, Israel, September 1, 2026 Medibyt, a digital health company focused on cardiopulmonary diagnostics, has announced that the U.S....
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Medical Devices, Diagnostics, Radiation-Emitting Products
Herzliya, Israel, September 1, 2026 Medibyt, a digital health company focused on cardiopulmonary diagnostics, has announced that the U.S....
Freiburg, Germany, August 31, 2026 Kazia Therapeutics has announced plans to expand its ongoing paxalisib clinical trial into hormone...
Dublin, Ireland, September 1, 2026 Keenova Therapeutics plc has announced new initiatives for the second annual National Hand Health...
SAN ANTONIO, September 1, 2026 bioAffinity Technologies, Inc. is advancing the potential use of its noninvasive CyPath® Lung test...
NEW YORK, September 2, 2026 Intelligent Bio Solutions Inc. has reported strong performance results for its Intelligent Fingerprinting Drug...
MELBOURNE, Australia and INDIANAPOLIS, September 2, 2026 Telix Pharmaceuticals Limited has completed enrollment of 350 patients in its Phase...
BURLINGTON, Mass. & NEW YORK, September 1, 2026 Butterfly Network, Inc. and Merge Labs have entered a multi-year licensing...
PALO ALTO, Calif., Sept. 1, 2026 Guardant Health announced that its Shield blood test for colorectal cancer (CRC) screening...
AUSTIN, Texas, September 1, 2026 Natera announced publication of new clinical data in Blood Neoplasia supporting the prognostic and...
CHICAGO, August 31, 2026 GE HealthCare announced that its Photonovaâ„¢ Spectra photon-counting computed tomography (PCCT) system has received CE...
